Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 17.15% to -10 cents per share on August 19

Q2'26

Est.

$-0.11

Q1'26

Missed

by $0.07

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.10

The last earnings report on May 14 showed earnings per share of -12 cents, missing the estimate of -5 cents. With 510.61K shares outstanding, the current market capitalization sits at 269.82M.

View a ticker or compare two or three

Compare

IVVD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IVVD